Gut-organ axis: a microbial outreach and networking
- PMID: 32472555
- DOI: 10.1111/lam.13333
Gut-organ axis: a microbial outreach and networking
Abstract
Human gut microbiota (GM) includes a complex and dynamic population of microorganisms that are crucial for well-being and survival of the organism. It has been reported as diverse and relatively stable with shared core microbiota, including Bacteroidetes and Firmicutes as the major dominants. They are the key regulators of body homeostasis, involving both intestinal and extra-intestinal effects by influencing many physiological functions such as metabolism, maintenance of barrier homeostasis, inflammation and hematopoiesis. Any alteration in GM community structures not only trigger gut disorders but also influence other organs and cause associated diseases. In recent past, the GM has been defined as a 'vital organ' with its involvement with other organs; thus, establishing a link or a bi- or multidirectional communication axis between the organs via neural, endocrine, immune, humoral and metabolic pathways. Alterations in GM have been linked to several diseases known to humans; although the exact interaction mechanism between the gut and the organs is yet to be defined. In this review, the bidirectional relationship between the gut and the vital human organs was envisaged and discussed under several headings. Furthermore, several disease symptoms were also revisited to redefine the communication network between the gut microbes and the associated organs.
Keywords: gut microbiota; gut-adipose axis; gut-bone axis; gut-brain axis; gut-heart axis; gut-kidney axis; gut-liver axis; gut-skin axis.
© 2020 The Society for Applied Microbiology.
Similar articles
-
Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.Pflugers Arch. 2020 Mar;472(3):303-320. doi: 10.1007/s00424-020-02352-x. Epub 2020 Feb 17. Pflugers Arch. 2020. PMID: 32064574 Review.
-
The Gut-Liver Axis in the Control of Energy Metabolism and Food Intake in Animals.Annu Rev Anim Biosci. 2020 Feb 15;8:295-319. doi: 10.1146/annurev-animal-021419-083852. Epub 2019 Nov 5. Annu Rev Anim Biosci. 2020. PMID: 31689373 Review.
-
Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature.Int J Mol Sci. 2019 Jan 17;20(2):395. doi: 10.3390/ijms20020395. Int J Mol Sci. 2019. PMID: 30658519 Free PMC article. Review.
-
The role of gut-islet axis in pancreatic islet function and glucose homeostasis.Diabetes Obes Metab. 2025 Apr;27(4):1676-1692. doi: 10.1111/dom.16225. Epub 2025 Feb 6. Diabetes Obes Metab. 2025. PMID: 39916498 Free PMC article. Review.
-
Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.Ageing Res Rev. 2018 Aug;45:53-61. doi: 10.1016/j.arr.2018.04.004. Epub 2018 Apr 26. Ageing Res Rev. 2018. PMID: 29705121 Review.
Cited by
-
Causal relationship of gut microbiota with diabetic nephropathy: a Mendelian randomization analysis.Front Microbiol. 2024 Jan 3;14:1281361. doi: 10.3389/fmicb.2023.1281361. eCollection 2023. Front Microbiol. 2024. PMID: 38235430 Free PMC article.
-
Recent Review on Selected Xenobiotics and Their Impacts on Gut Microbiome and Metabolome.Trends Analyt Chem. 2023 Sep;166:117155. doi: 10.1016/j.trac.2023.117155. Epub 2023 Jun 28. Trends Analyt Chem. 2023. PMID: 37484879 Free PMC article.
-
Gut microbiota in health and disease: advances and future prospects.MedComm (2020). 2024 Nov 20;5(12):e70012. doi: 10.1002/mco2.70012. eCollection 2024 Dec. MedComm (2020). 2024. PMID: 39568773 Free PMC article. Review.
-
Involvement of intestinal mucosal microbiota in adenine-induced liver function injury.3 Biotech. 2025 Jan;15(1):6. doi: 10.1007/s13205-024-04180-7. Epub 2024 Dec 12. 3 Biotech. 2025. PMID: 39676888
-
The effects of stress on gut virome: Implications on infectious disease and systemic disorders.Microbiologyopen. 2024 Oct;13(5):e1434. doi: 10.1002/mbo3.1434. Microbiologyopen. 2024. PMID: 39311537 Free PMC article. Review.
References
-
- Abrahamsson, T.R., Jakobsson, H.E., Andersson, A.F., Björkstén, B., Engstrand, L. and Jenmalm, M.C. (2012) Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol 129, 434-440.
-
- Ahluwalia, V., Betrapally, N.S., Hylemon, P.B., White, M.B., Gillevet, P.M., Unser, A.B., Fagan, A., Daita, K. et al. (2016) Impaired gut-liver-brain axis in patients with cirrhosis. Sci Rep 6, https://doi.org/10.1038/srep26800.
-
- Amar, J., Lelouvier, B., Servant, F., Lluch, J., Burcelin, R., Bongard, V. and Elbaz, M. (2019) Blood microbiota modification after myocardial infarction depends upon low-density lipoprotein cholesterol levels. J Am Heart Assoc 8, e011797.
-
- Amon, P. and Sanderson, I. (2017) What is the microbiome? Arch Dis Childhood-E 102, 257-260. https://doi.org/10.1136/archdischild-2016-311643.
-
- Bäckhed, F. (2013) Meat-metabolizing bacteria in atherosclerosis. Nat Med 19, 533-534.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous